Commercial Post-marketing oncology studies: Enabling faster recruitment and lower costs Pharmaceutical TechnologyIn clinical trials, post-marketing approval studies remain a lower priority than other research areas, especially at community oncology centers.OncologyRead full story pharminent June 22, 2026 (Last updated: June 22, 2026) Pharmaceutical Technology In clinical trials, post-marketing approval studies remain a lower priority than other research areas, especially at community oncology centers. Oncology Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Sun Pharma to acquire Innovcare Lifesciences for $28.7mNext: Insilico and SK Bio forge $2.5bn AI neuroimmunity alliance Related Stories Commercial Wegovy pill launches in UK as first daily oral GLP1 for weight management pharminent July 6, 2026 Commercial Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval pharminent June 26, 2026 Commercial Lilly launches its LillyDirect sales channel in the UK pharminent June 25, 2026
